Holen Sie sich die Stockscreener-App
9.85
0.10%
-0.010
Handel nachbörslich:
9.85
Schlusskurs vom Vortag:
$9.86
Offen:
$9.85
24-Stunden-Volumen:
1,800
Relative Volume:
0.03
Marktkapitalisierung:
$332.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-0.10%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.85
$9.86
1-Wochen-Bereich:
$9.85
$9.87
52-Wochen-Spanne:
$9.84
$9.87
Bleichroeder Acquisition Corp I Stock (BACQ) Company Profile
Firmenname
Bleichroeder Acquisition Corp I
Sektor
Branche
Telefon
(917) 769-2999
Adresse
1345 AVENUE OF THE AMERICAS, NEW YORK
Vergleichen Sie BACQ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BACQ
Bleichroeder Acquisition Corp I
|
9.85 | 332.52M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
7.06 | 2.04B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
OBDE
Blue Owl Capital Corp Iii
|
15.04 | 1.86B | 244.17M | 216.39M | -461.29M | 1.7559 |
|
AACT
Ares Acquisition Corporation Ii
|
10.95 | 684.38M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.47 | 451.52M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.08 | 443.34M | 0 | 0 | 0 | 0.00 |
Bleichroeder Acquisition Corp I Aktie (BACQ) Neueste Nachrichten
Bleichroeder Acquisition Corp. I (BACQ) reports earnings - Quartz
Bleichroeder Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing December 2, 2024 - The Manila Times
Revival Gold Announces AGM Results and Transition in Exploration Leadership - The Manila Times
Bleichroeder Acquisition Corp. I Announces Unit Split for Nasdaq Trading - StockTitan
Bleichroeder Acquisition announces IPO proceeds and trust account - Investing.com
BACQUBleichroeder Acquisition Corp. I Unit Latest Stock News & Market Updates - StockTitan
U.S. IPO Weekly Recap: 2 Nano-Caps List As More Small Names Join The Pipeline - Seeking Alpha
Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease - The Manila Times
Welltower Announces Addition of Andrew Gundlach to Board of Directors - PR Newswire
Deal Watch: Private Equity-Backed Deals Headline Week - Law.com
IPO NewsUS IPO Weekly Recap: 2 SPACs debut in quiet post-holiday week - Renaissance Capital
How a hedge fund manager launched a biz journalism media start-up - Talking Biz News
Private equity manager Blackstone breaks into mutual fund business with First Eagle buy - InvestmentNews
Finanzdaten der Bleichroeder Acquisition Corp I-Aktie (BACQ)
Es liegen keine Finanzdaten für Bleichroeder Acquisition Corp I (BACQ) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):